Your search returned 2 results.

Results
	1.	Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy. [electronic resource] by Burris, Howard A Rugo, Hope S Vukelja, Svetislava J Vogel, Charles L Borson, Rachel A Limentani, Steven Tan-Chiu, Elizabeth Krop, Ian E Michaelson, Richard A Girish, Sandhya Amler, Lukas Zheng, Maoxia Chu, Yu-Waye Klencke, Barbara O'Shaughnessy, Joyce A Producer: 20110310 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. [electronic resource] by Winer, Eric P Berry, Donald A Woolf, Susan Duggan, David Kornblith, Alice Harris, Lyndsay N Michaelson, Richard A Kirshner, Jeffrey A Fleming, Gini F Perry, Michael C Graham, Mark L Sharp, Stewart A Keresztes, Roger Henderson, I Craig Hudis, Clifford Muss, Hyman Norton, Larry Producer: 20040618 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search